a
Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China
b Phase I Clinical Research Unit, West China Hospital, Sichuan University, Chengdu, China
b Phase I Clinical Research Unit, West China Hospital, Sichuan University, Chengdu, China
Abstract
The aim of this study
was to evaluate evidence for the efficacy of aloe vera on managing
prediabetes and early non-treated diabetes mellitus. We performed a
systematic search of PubMed, Embase, and Cochrane Central Register of
Controlled Trials until 28 January 2016. A total of five randomized
controlled trials (RCTs) involving 415 participants were included.
Compared with the controls, aloe vera supplementation significantly
reduced the concentrations of fasting blood glucose (FBG) (p = 0.02;
weighed mean difference [WMD]: −30.05 mg/dL; 95% confidence interval
[CI]: −54.87 to −5.23 mg/dL), glycosylated hemoglobin A1c (HbA1c) (p
< 0.00001; WMD: −0.41%; 95% CI: −0.55% to −0.27%), triglyceride (p =
0.0001), total cholesterol (TC) (p < 0.00001), and low density
lipoprotein-cholesterol (LDL-C) (p < 0.00001). Aloe vera was superior
to placebo in increasing serum high density lipoprotein-cholesterol
(HDL-C) levels (p = 0.04). Only one adverse event was reported. The
evidence from RCTs showed that aloe vera might effectively reduce the
levels of FBG, HbA1c, triglyceride, TC and LDL-C, and increase the
levels of HDL-C on prediabetes and early non-treated diabetic patients.
Limited evidence exists about the safety of aloe vera. Given the small
number and poor quality of RCTs included in the meta-analysis, these
results are inconclusive. A large-scale, well-designed RCT is needed to
further address this issue. © 2016 by the authors; licensee MDPI, Basel,
Switzerland.
Author keywords
Aloe vera; Meta-analysis; Prediabetes; Randomized controlled trials
ISSN: 20726643Source Type: Journal
Original language: English
DOI: 10.3390/nu8070388Document Type: Article
Publisher: MDPI AG
Tian, H.; Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, China; email:hmtian999@126.com
© Copyright 2016 Elsevier B.V., All rights reserved.
© Copyright 2016 Elsevier B.V., All rights reserved.